Efficacy and Safety of Opicapone in Clinical Practice

NCT02847442 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

518

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease With Wearing-off Motor Fluctuations

Interventions

DRUG: BIA 9-1067
DRUG: levodopa/dopa decarboxylase inhibitor

Sponsor

Bial - Portela C S.A.